[177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial

Eric Baudin, Alice Durand, Amandine Beron, Denis Smith, Désirée Déandreis, David Taieb, Catherine Ansquer, Lawrence Dierickx, Emmanuel Deshayes, Olivia Hentic, Salma Moalla, Yves Menu, Rachida Lebtahi, Eric Assenat, Yann Touchefeu, Rosine Guimbaud, Laetitia Dahan, Livia Lamartina, Nadir Cheurfa, Elske Quak, Karine Bouhier-Leporrier, Magalie Haissaguerre, Elif Hindie, Christine Do Cao, Catherine Lombard-Bohas, Arnaud Jannin, Thomas Walter, Michel Ducreux, Sarah Chaib, Julien Hadoux, Stephanie Foulon

Open source

DOI: 10.1016/s1470-2045(26)00108-7
Published: 2026-06
Container: The Lancet Oncology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-26-00108-7,
  title = {[177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial},
  author = {Eric Baudin and Alice Durand and Amandine Beron and Denis Smith and Désirée Déandreis and David Taieb and Catherine Ansquer and Lawrence Dierickx and Emmanuel Deshayes and Olivia Hentic and Salma Moalla and Yves Menu and Rachida Lebtahi and Eric Assenat and Yann Touchefeu and Rosine Guimbaud and Laetitia Dahan and Livia Lamartina and Nadir Cheurfa and Elske Quak and Karine Bouhier-Leporrier and Magalie Haissaguerre and Elif Hindie and Christine Do Cao and Catherine Lombard-Bohas and Arnaud Jannin and Thomas Walter and Michel Ducreux and Sarah Chaib and Julien Hadoux and Stephanie Foulon},
  year = {2026},
  journal = {The Lancet Oncology},
  doi = {10.1016/s1470-2045(26)00108-7},
  url = {https://doi.org/10.1016/s1470-2045(26)00108-7}
}

RIS

TY  - JOUR
TI  - [177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial
AU  - Eric Baudin
AU  - Alice Durand
AU  - Amandine Beron
AU  - Denis Smith
AU  - Désirée Déandreis
AU  - David Taieb
AU  - Catherine Ansquer
AU  - Lawrence Dierickx
AU  - Emmanuel Deshayes
AU  - Olivia Hentic
AU  - Salma Moalla
AU  - Yves Menu
AU  - Rachida Lebtahi
AU  - Eric Assenat
AU  - Yann Touchefeu
AU  - Rosine Guimbaud
AU  - Laetitia Dahan
AU  - Livia Lamartina
AU  - Nadir Cheurfa
AU  - Elske Quak
AU  - Karine Bouhier-Leporrier
AU  - Magalie Haissaguerre
AU  - Elif Hindie
AU  - Christine Do Cao
AU  - Catherine Lombard-Bohas
AU  - Arnaud Jannin
AU  - Thomas Walter
AU  - Michel Ducreux
AU  - Sarah Chaib
AU  - Julien Hadoux
AU  - Stephanie Foulon
PY  - 2026
JO  - The Lancet Oncology
DO  - 10.1016/s1470-2045(26)00108-7
UR  - https://doi.org/10.1016/s1470-2045(26)00108-7
ER  -

APA

Baudin, E., Durand, A., Beron, A., Smith, D., Déandreis, D., Taieb, D., Ansquer, C., Dierickx, L., Deshayes, E., Hentic, O., Moalla, S., Menu, Y., Lebtahi, R., Assenat, E., Touchefeu, Y., Guimbaud, R., Dahan, L., Lamartina, L., Cheurfa, N., Quak, E., Bouhier-Leporrier, K., Haissaguerre, M., Hindie, E., Cao, C. D., Lombard-Bohas, C., Jannin, A., Walter, T., Ducreux, M., Chaib, S., Hadoux, J., & Foulon, S. (2026). [177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(26)00108-7

Source records

crossref · retrieved 2026-11-10T14:35:51.342Z